冠状动脉旁路移植术同期行外科消融可经济有效地降低死亡率
研究分析了2013年3745例需行冠状动脉旁路移植术(CABG)的医保房颤患者,其中17%同期接受外科消融(SA)。SA可能是一种经济有效的干预措施,可提高CABG合并房颤患者的2年生存率。
要点
- SA组晚期死亡风险显著降低(HR 0.71,95%CI 0.52-0.97)
- SA组初始住院费用较高(RR 1.11),但2年总住院费用无差异
- SA组房颤再入院(HR 1.14)和起搏器/除颤器植入(HR 1.37)风险较高
核心结论
- SA组初始住院费用较高,但2年内总住院费用无显著差异,提示SA可能具有成本效益。
研究设计与样本
- 回顾性队列研究,纳入2013年3745例需行CABG的医保房颤患者,其中626例(17%)同期行SA。
- 采用分段Cox比例风险模型(0-90天和91-729天)进行风险校正,比较两组2年内的死亡率、并发症和费用。
临床怎么用
- 对于需行CABG的房颤患者,可考虑同期行SA以降低晚期死亡风险,但需权衡初始费用增加和起搏器植入风险。
局限性
- 研究为回顾性观察性设计,可能存在选择偏倚和未测量的混杂因素。
- 仅纳入医保受益人,结果可能不适用于其他人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the longitudinal impact of surgical ablation (SA) for atrial fibrillation (AF) in patients undergoing coronary artery bypass grafting (CABG) remain limited. This study examined 2-year risk-adjusted mortality and total hospital costs in Medicare beneficiaries with AF requiring CABG with or without SA. METHODS: CABG was performed in 3745 Medicare beneficiaries with AF in 2013, with concomitant SA in 17% (626 of 3745). Risk-adjusted mortality, morbidity, and cost during the first 2 postoperative years for patients with SA and those without SA were compared. A piecewise Cox proportional hazard model (0-90 days and 91-729 days) was used to risk-adjust mortality. RESULTS: Compared with the no SA group, the SA group had lower rates of heart failure before surgery (31% vs 36%), chronic lung disease (27% vs 33%), renal failure (4% vs 7%), and urgent or emergent presentation (34% vs 49%) (all P < .05). Risk-adjusted index admission costs were higher with SA (rate ratio [RR], 1.11; P < .01), as were readmissions for AF (hazard ratio [HR], 1.14; 95% confidence interval [CI], 1.00-1.29; P = .04) and pacemaker/defibrillator implantation (HR, 1.37; 95%, 1.08-1.74; P = .01). Risk-adjusted inpatient days and inpatient costs were similar after 2 years (RR, 0.97; P = .31 and RR = 1.04; P = .17, respectively); however, the risk-adjusted hazard for late mortality (91-729 days) was significantly lower with SA (HR, 0.71; 95% CI, 0.52-0.97; P = .03). CONCLUSIONS: In patients with AF requiring CABG, SA was associated with a 29% lower risk-adjusted hazard for late mortality. Index hospital costs were higher with SA, but total inpatient costs were not different in the 2 groups after 2 years. SA appears to be a cost-effective intervention to enhance late 2-year survival in patients with AF undergoing CABG.
引用
- Rankin JS, Lerner DJ, Braid-Forbes MJ, et al. Surgical ablation of atrial fibrillation concomitant to coronary-artery bypass grafting provides cost-effective mortality reduction. J Thorac Cardiovasc Surg. 2019. PMID: 31610956. doi:10.1016/j.jtcvs.2019.07.131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。